OSCR
Overvalued by 220.3% based on the discounted cash flow analysis.
Market cap | $3.64 Billion |
---|---|
Enterprise Value | $3.94 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.22 |
Beta | 1.52 |
Outstanding Shares | 201,709,432 |
Avg 30 Day Volume | 3,413,657 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -67.9 |
---|---|
PEG | 12.44 |
Price to Sales | 0.55 |
Price to Book Ratio | 3.53 |
Enterprise Value to Revenue | 0.6 |
Enterprise Value to EBIT | -159.48 |
Enterprise Value to Net Income | -74 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | 0.29 |
No data
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...